Skip to content
zameds

Aranesp

Darbepoetin alfa

S4

No structure available

This product's active ingredient could not be matched to a single known compound.

Registration

Applicants
1
Registrations
12
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Amgen south africa (pty)ltdAranesp10 ug, 15 ug, 20 ug, 30 ug, 40 ug, 50 ug, 60 ug, 80 ug, 100 ug, 150 ug, 300 ug, 500 ug410884, 410885, 410886, 410887, 410888, 410889, 410890, 410891, 410892, 410893, 410894, 410895S4PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Aranesp 10 ug

EACH O,4 ml SOLUTION CONTAINS DARBEPOETIN ALFA 10,0 ug

10 ug41088441/8.3/0884RegisteredS4PIPIL
Aranesp 15 ug

EACH O,375 ml SOLUTION CONTAINS DARBEPOETIN ALFA 15,0 ug

15 ug41088541/8.3/0885RegisteredS4PIPIL
Aranesp 20 ug

EACH O,5 ml SOLUTION CONTAINS DARBEPOETIN ALFA 20,0 ug

20 ug41088641/8.3/0886RegisteredS4PIPIL
Aranesp 30 ug

EACH O,3 ml SOLUTION CONTAINS DARBEPOETIN ALFA 30,0 ug

30 ug41088741/8.3/0887RegisteredS4PIPIL
Aranesp 40 ug

EACH O,4 ml SOLUTION CONTAINS DARBEPOETIN ALFA 40,0 ug

40 ug41088841/8.3/0888RegisteredS4PIPIL
Aranesp 50 ug

EACH O,5 ml SOLUTION CONTAINS DARBEPOETIN ALFA 50,0 ug

50 ug41088941/8.3/0889RegisteredS4PIPIL
Aranesp 60 ug

EACH O,3 ml SOLUTION CONTAINS DARBEPOETIN ALFA 60,0 ug

60 ug41089041/8.3/0890RegisteredS4PIPIL
Aranesp 80 ug

EACH O,4 ml SOLUTION CONTAINS DARBEPOETIN ALFA 80,0 ug

80 ug41089141/8.3/0891RegisteredS4PIPIL
Aranesp 100 ug

EACH O,5 ml SOLUTION CONTAINS DARBEPOETIN ALFA 100,0 ug

100 ug41089241/8.3/0892RegisteredS4PIPIL
Aranesp 150 ug

EACH O,3 ml SOLUTION CONTAINS DARBEPOETIN ALFA 150,0 ug

150 ug41089341/8.3/0893RegisteredS4PIPIL
Aranesp 300 ug

EACH O,6 ml SOLUTION CONTAINS DARBEPOETIN ALFA 300,0 ug

300 ug41089441/8.3/0894RegisteredS4PIPIL
Aranesp 500 ug

EACH 1,O ml SOLUTION CONTAINS DARBEPOETIN ALFA 500,0 ug

500 ug41089541/8.3/0895RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Darbepoetin alfa

  • S4: Darbepoetin alfa

    Consolidated Schedules 06 July 2026, line 5952

Pharmacological class: Erythropoietics (haematinics). (class 8.3)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

Professional information (PI)For healthcare professionalsAranesp 10 ug, Amgen south africa (pty)ltd. SAHPRA's document for ARANESPPatient information leaflet (PIL)For patients and carersAranesp 10 ug, Amgen south africa (pty)ltd. SAHPRA's document for ARANESP

These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles